Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 3:12:812678.
doi: 10.3389/fneur.2021.812678. eCollection 2021.

Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit

Affiliations
Review

Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit

Monica P Mallampalli et al. Front Neurol. .

Abstract

Vestibular migraine (VM) is an increasingly recognized pathology yet remains as an underdiagnosed cause of vestibular disorders. While current diagnostic criteria are codified in the 2012 Barany Society document and included in the third edition of the international classification of headache disorders, the pathophysiology of this disorder is still elusive. The Association for Migraine Disorders hosted a multidisciplinary, international expert workshop in October 2020 and identified seven current care gaps that the scientific community needs to resolve, including a better understanding of the range of symptoms and phenotypes of VM, the lack of a diagnostic marker, a better understanding of pathophysiologic mechanisms, as well as the lack of clear recommendations for interventions (nonpharmacologic and pharmacologic) and finally, the need for specific outcome measures that will guide clinicians as well as research into the efficacy of interventions. The expert group issued several recommendations to address those areas including establishing a global VM registry, creating an improved diagnostic algorithm using available vestibular tests as well as others that are in development, conducting appropriate trials of high quality to validate current clinically available treatment and fostering collaborative efforts to elucidate the pathophysiologic mechanisms underlying VM, specifically the role of the trigemino-vascular pathways.

Keywords: chronic migraine (CM); trigemino-vascular pathway; vertigo-pathophysiology; vestibular disorders; vestibular migraine.

PubMed Disclaimer

Conflict of interest statement

NS serves on the speaker's bureau for Abbvie and Amgen as well as an educational consultant to Amgen. FG serves on the speakers bureau for BioHaven and Amgen and as a consultant for Allergan. HD has a patent pending: “Combination therapy for the treatment of vertigo.” The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Huang TC, Wang SJ, Kheradmand A. Vestibular migraine: an update on current understanding and future directions. Cephalalgia. (2020) 40:107–21. 10.1177/0333102419869317 - DOI - PubMed
    1. Lin HW, Bhattacharyya N. Impact of dizziness and obesity on the prevalence of falls and fall-related injuries. Laryngoscope. (2014) 124:2797–801. 10.1002/lary.24806 - DOI - PubMed
    1. Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol. (2018) 39:1037–44. 10.1097/MAO.0000000000001900 - DOI - PubMed
    1. Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol. (2016) 263 (Suppl 1):S82–9. 10.1007/s00415-015-7905-2 - DOI - PMC - PubMed
    1. Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. (2001) 56:436–41. 10.1212/WNL.56.4.436 - DOI - PubMed